Changes in oxidative balance in rat pericytes exposed to diabetic conditions

Journal of Cellular and Molecular Medicine

Volumn 8, Issue 1, 2004, Pages 117-126

  Manea, A ^a   Constantinescu, Elena ^a   Popov, Doina ^a   Raicu, Monica ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Diabetes; Oxidative stress; Pericytes; Retinopathy

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; CALCIUM; CATALASE; COLORING AGENT; DIACETYLDICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE; FREE RADICAL; FURA 2; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LYSINE; OXYGEN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DIABETES MELLITUS; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PERICYTE; RAT; SPECTROFLUOROMETRY;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BASEMENT MEMBRANE; CALCIUM; CATALASE; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; FREE RADICALS; FURA-2; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LYSINE; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; OXYGEN; PERICYTES; RATS; REACTIVE OXYGEN SPECIES; SPECTROMETRY, FLUORESCENCE; SUPEROXIDE DISMUTASE;

EID: 3142718936     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2004.tb00266.x     Document Type: Article

References (48)

1. Chakrabarti S., Cukernik M., Hileeto D., Evans T., Chen S., Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy, Diabetes Metab. Res. Rev., 16: 393-407, 2000
2. Cai J., Boulton M., The pathogenesis of diabetic retinopathy: old concepts and new question, Eye, 16: 242-26, 2002
3. Hammes H.P., Lin J., Renner O., Shani M., Lundqvist A., Betsholtz C., Brownlee M., Deutsch U., Pericytes and the pathogenesis of diabetic retinopathy, Diabetes, 51: 3107-3112, 2002
4. Kowlurn R.A., Kennedy A., Therapeutic potential of antioxidants and diabetes retinopathy, Expert Opin. Investig. Drugs, 10: 1665-1676, 2001
5. Terada L., Oxidative stress and endothelial activation, Crit. Care Med., 30: S186-S191, 2002
6. Sorescu D., Weiss D., Lassegue B., Clempu R.E., Szocs K. et al., Superoxide production and expression of Nox family proteins in human atherosclerosis, Circulation, 105: 1429-1435, 2002
7. Schnackenberg C.G., Oxygen radicals in cardiovascularrenal disease, Curr. Opin. Pharmacol., 2: 121-125, 2002
8. Kaneda H., Taguchi G., Ogasawara K., Aizawa T., Ohno M., Increased level of advanced oxidation protein products in patients with coronary heart disease, Atherosclerosis, 162: 221-225, 2002
9. Jandeleit-Dahm K., Cooper M.E., Hypertension and diabetes, Curr. Opin. Nephrol. Hypertens, 11: 221-228, 2002
10. Vincent A.M., Brownlee M., Russel J.W., Oxidative stress and programmed cell death in diabetic neuropathy, Ann. NY Acad. Sci., 959: 368-383, 2002
11. Noor R., Mittal S., Iqbar J., Superoxide dismutase - applications and relevance to human disease, Med. Sci. Monit., 8: 210-215, 2002
12. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delartre J., Consequences of the diabetic status on the oxidant/antioxidant balance, Diabetes and Metabolism, 26: 163-176, 2000
13. Stitt A.W., Advanced glycation: an important pathological event in diabetic and age related ocular disease, Br. J. Ophthalmol., 85: 746-753, 2001
14. Touyz R.M., Schffrin E.L., Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phopholipase D-dependent NAD(P)H oxidase-sensitive pathways, J. Hypertens., 19: 1245-1254, 2001
15. Wautier M.P., Chappey O., Corda S., Schmidt A.M., Wautier J.L., Activation of NADPH oxidase by AGE links oxidant stress altered gene expression via RAGE, Am. J. Physiol. Endocrinol. Metab., 280: E655-E694, 2001
16. 2 in angiotensin II-induced vascular hypertrophy, Hypertension, 32; 488-495, 1998
17. Warnholtz A., Nickening G., Schultz E., Increased NADH oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system, Circulation, 99: 2027-2033, 1999
18. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., Schmidt H.H.H.W., Upregulation of the vascular NAD(P)H -oxidase isoform NOX 1 and NOX 4 by the renin-angiotensin system in vitro and in vivo, Free Rad. Biol. Med., 31; 1456-1464, 2001
19. Mueller C., Baudler S., Welzel H., Bohm M., Nickening G., Identification of a novel redox sensitive gene, Id3 which mediates angiotensin II induced cell growth, Circulation, 105: 2623-2628, 2002
20. Zalba G., San Jose G., Moreno M.U., Fortuno M.A., Beaumont F.J., Diez J., Oxidative stress in arterial hypertension. Role of NAD(P)H oxidase, Hypertension, 38: 1395-1399, 2001
21. Sowers J.R., Hypertension, angiotensin II and oxidative stress, N. Engl. J. Med., 346: 1999-2001, 2002
22. Rathaus M., Bernheim J., Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension, Nephrol. Dial. Transplant., 17: 216-221, 2002
23. Griendling K.K., Sorescu D., Ushio-Fukai M., NAD(P)H oxidase. Role in cardiovascular biology and disease, Circ. Res., 86: 494-501, 2001
24. Li J.M., Gall N.P., Grieve D.J., Chen M., Shah A.M., Activation of NADPH oxidase during progression of cardiac hypertrophy to failure, Hypertension, 40: 477-484, 2002
25. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K.M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase, Circulation, 105: 1656-1662, 2002
26. Bucala R., Tracey K.J., Cerami A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes, J. Clin Invest., 87: 432-438, 1991
27. Eskenasy M., Tasca S.I., Culture of pericytes isolated from rat adipose microvasculature and characterization of their prostanoid production, Cell. Biol. Int. Rep., 12: 105-1066, 1988
28. Paoletti F., Mocali A., Determination of superoxide dismutase activity by purely chemical system based on NADPH oxidation, Meth. Enzymol., 186: 209-220, 1990
29. Paget C., Lecomte M., Ruggiero D., Wiernsperger N., Lagarde M., Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products, Free Rad. Biol. Med., 25: 121-129, 1998
30. Annuk M., Zilmer M., Lind L., Linse T., Feulstrom B., Oxidative stress and endothelial function in chronic renal failure, J. Am. Soc. Nephrol., 12: 2747-2752, 2001
31. Myhre O., Andersen J.M., Aarnes H., Fonnum F., Evaluation of the probe 2″,7″-dichlorofluorescein diacetate, luminol, and fucigenin as indicators of reactive species formation, Biochem. Pharmacol., 65: 575-582, 2003
32. 2+ indicators with greatly improved fluorescent properties, J. Biochem., 260: 3440-3450, 1985
33. Byrne J.A., Grieve D.J., Cave A.C., Shah A.M., Oxidative stress and heart failure, Arch. Mal Coeur Vaiss., 96: 214-221, 2003
34. Itoh S., Unemoto S., Hiromoto M., Toma Y., Tomochika Y., Aoyagi S., Tanaka M., Fujii T., Masuzaki M., Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis, Circulation, 105: 2288-2295, 2002
35. Spitaler M.M., Graier W.F., Vascular targets of redox signaling in diabetes mellitus, Diabetologia, 45: 476-494, 2002
36. Ceriello A., New insights on oxidative stress and diabetic complications may lead to a "Causal" antioxidant therapy, Diabetes Care, 26: 189-1596, 2003
37. Touyz R.M., Recent advances in intracellular signaling in hypertension, Curr. Opin. Nephrol. Hypertens., 2: 65-174, 2003
38. Virridis A., Schiffrin E.L., Vascular inflammation: a role in vascular disease in hypertension?, Curr. Opin. Nephrol. Hypertens., 12: 181-187, 2003
39. Evans J.I., Goddfine I.D., Maddux B.A., Brodsky G.M., Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta cell dysfunction? Diabetes, 52: 1-6, 2003
40. Sharpe P.G., Liu W.H., Yue K.K.M., McMaster D., Catherwood M.K., McGinty A.M., Trimble E.R., Glucose-induced oxidative stress in vascular contractile cells. Comparison of aortic smooth muscle cells and retinal pericytes, Diabetes, 47: 801-809, 1998
41. Hammes H.P., Wellensiek B., Kloting I., Sickel E., Bretzel R.G., Brownlee M., The relationship of glycaemic level to advanced glycation end-product (AGE) accumulating and retinal pathology in the spontaneous diabetic hamster, Diabetologia, 4: 165-170, 1998
42. phox homologues in vascular smooth muscle cells. Nox 1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways, Circ. Res., 88: 888-894, 2001
43. Levy J., Abnormal cell calcium homeostasis in type II diabetes mellitus, Endocrine, 10: 1-6, 1999
44. McGinty A.M., Scholfield C.N., Liu W.H., Anderson P., Hoey D.E.E., Trimble E.R., Effect of glucose on endothelin-1-induced calcium transients in cultured bovine retinal pericytes, J. Biol. Chem., 274: 25250-2253, 1999
45. Sakagami K., Kodama T., Puro D.G., PDGF-induced coupling of function with metabolism in microvascular pericytes of the retina, Invest. Ophthalmol. Vis. Sci., 42: 1939-1944, 2001
46. Sauer H., Wartenberg M., Hescheler J., Reactive oxygen species as intracellular messengers during cell growth and differentiation, Cell Physiol. Biochem., 11: 173-186, 2001
47. Pogan L., Garneau L., Bissonette P., Wu L., Sauer R., Abnormal calcium signaling in vascular endothelial cells from spontaneously hypertensive rats: role of free radicals, J. Hypertens., 9: 721-730, 2001
48. Gibson G.E., Zhang H., Xu H., Parc L.C., Jeitner T.M., Oxidative stress increases internal calcium stores an reduces a key mitochondrial enzyme, Biochem. Biophys. Acta., 16: 177-189, 2002